News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current GLABF market cap is 21M. The company's latest EPS is CAD -0.0810 and P/E is -3.46.
| Year End January 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 219k | 0 |
| Operating Income | -436k | -4.25M | -5.71M |
| Net Income | -834k | -4.74M | -5.98M |
| Year End January 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.53M | 1.42M | 1.88M |
| Total Liabilities | 2.37M | 476k | 1.95M |
| Total Equity | 160k | 944k | -72k |
| Year End January 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | |
| Operating | -320k | -3.87M | -4.51M |
| Investing | 14k | 8k | -505k |
| Financing | 1.19M | 4.14M | 3.94M |
| Market Cap | 21M |
| Price to Earnings Ratio | -3.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 254.55 |
| Price to Book Ratio | -286.88 |
| Dividend Yield | - |
| Shares Outstanding | 73.77M |
| Average Volume (1 week) | 4.5k |
| Average Volume (1 Month) | 6.6k |
| 52 Week Change | -47.27% |
| 52 Week High | 0.6957 |
| 52 Week Low | 0.284725 |
| Spread (Intraday) | 0.12 (33.29%) |
| Company Name | Gemina Laboratories Ltd (PK) |
| Address |
10th floor, 595 howe street vancouver, british columbia |
| Website | https://www.geminalabs.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
